摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(R)-6-{(1R,3aR,7aR)-4-[(S)-5-(tert-Butyl-dimethyl-silanyloxy)-4-methyl-5,6-dihydro-2H-thiopyran-3-ylethynyl]-7a-methyl-2,3,3a,6,7,7a-hexahydro-1H-inden-1-yl}-2-methyl-heptan-2-ol | 141666-56-0

中文名称
——
中文别名
——
英文名称
(R)-6-{(1R,3aR,7aR)-4-[(S)-5-(tert-Butyl-dimethyl-silanyloxy)-4-methyl-5,6-dihydro-2H-thiopyran-3-ylethynyl]-7a-methyl-2,3,3a,6,7,7a-hexahydro-1H-inden-1-yl}-2-methyl-heptan-2-ol
英文别名
——
(R)-6-{(1R,3aR,7aR)-4-[(S)-5-(tert-Butyl-dimethyl-silanyloxy)-4-methyl-5,6-dihydro-2H-thiopyran-3-ylethynyl]-7a-methyl-2,3,3a,6,7,7a-hexahydro-1H-inden-1-yl}-2-methyl-heptan-2-ol化学式
CAS
141666-56-0;141666-57-1
化学式
C32H54O2SSi
mdl
——
分子量
530.931
InChiKey
CBJVTLRLWNRUDP-MVAKELKPSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    8.77
  • 重原子数:
    36.0
  • 可旋转键数:
    7.0
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.81
  • 拓扑面积:
    29.46
  • 氢给体数:
    1.0
  • 氢受体数:
    3.0

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    参考文献:
    名称:
    Studies of vitamin D (calciferol) and its analogs. 42. 3-Deoxy-3-thia-1.alpha.,25-dihydroxyvitamin D3 and its 1.beta.-epimer: synthesis and biological evaluation
    摘要:
    The syntheses of 3-deoxy-3-thia-1-alpha,25-dihydroxyvitamin D3 (5a) and its 1-beta-epimer 5b have been achieved starting from CD-fragment 10 and the enantiomerically pure A-rings 11a and 11b prepared from thia 1,3-diketone 13. For the preparation of 11a and 11b, the thia diketone 13 was converted in two steps to the trimethylsilyl enynone 18. In the most effective route, the latter was asymmetrically reduced using (R)- or (S)-oxazaborolidine 24 and 25 and catecholborane to afford 19a (87% ee) and 19b (85% ee), respectively. Final enrichment to 11a and 11b was achieved via their crystalline carbamates 23a and 22b and then hydrolysis to the enantiomerically pure enynols 12a and 12b and silylated to the desired 11a and 11b. The absolute configuration at C-1 of the A-ring was examined in detail through four empirical correlation methods. The elution order of carbamates 22 and 23 by HPLC correlates with Pirkle's empirical rules. The specific rotations of enynols (-)-12a and (+)-12b correlate with Mills' rules for absolute configurations of chiral cyclohexenols. The enantiomeric sense of asymmetric reduction using the (R)- or (S)-oxazaborolidines and a complementary asymmetric reduction using LiAlH4 and N-methylephedrine was exactly that predicted. The C-1 absolute configuration of (S,S)-carbamate 22b was in fact fully confirmed by a single-crystal X-ray crystallographic study. Hence, the four empirically derived methods for establishing absolute configuration of the various enynols were mutually consistent. The analogues 5a and 5b were submitted for biological evaluation of their relative ability, in relation to the reference 1-alpha,25-dihydroxyvitamin D3 (3, 1-alpha,25-(OH)2-D3), to stimulate intestinal calcium absorption (ICA) and bone calcium mobilization (BCM) under in vivo conditions. Analogue 5a was 20% and <10% while analogue 5b was <20% and <10% as active as a 100 pmol dose of 1-alpha,25-(OH)2-D3 for ICA and BCM, respectively. In addition, 5a and 5b were 14.5 +/- 5.7% and 1.23 +/- 0.38%, respectively, as effective as 1-alpha,25-(OH)2-D3 in binding, under in vitro conditions, to a chick intestinal nuclear receptor.
    DOI:
    10.1021/jo00040a025
  • 作为产物:
    描述:
    参考文献:
    名称:
    Studies of vitamin D (calciferol) and its analogs. 42. 3-Deoxy-3-thia-1.alpha.,25-dihydroxyvitamin D3 and its 1.beta.-epimer: synthesis and biological evaluation
    摘要:
    The syntheses of 3-deoxy-3-thia-1-alpha,25-dihydroxyvitamin D3 (5a) and its 1-beta-epimer 5b have been achieved starting from CD-fragment 10 and the enantiomerically pure A-rings 11a and 11b prepared from thia 1,3-diketone 13. For the preparation of 11a and 11b, the thia diketone 13 was converted in two steps to the trimethylsilyl enynone 18. In the most effective route, the latter was asymmetrically reduced using (R)- or (S)-oxazaborolidine 24 and 25 and catecholborane to afford 19a (87% ee) and 19b (85% ee), respectively. Final enrichment to 11a and 11b was achieved via their crystalline carbamates 23a and 22b and then hydrolysis to the enantiomerically pure enynols 12a and 12b and silylated to the desired 11a and 11b. The absolute configuration at C-1 of the A-ring was examined in detail through four empirical correlation methods. The elution order of carbamates 22 and 23 by HPLC correlates with Pirkle's empirical rules. The specific rotations of enynols (-)-12a and (+)-12b correlate with Mills' rules for absolute configurations of chiral cyclohexenols. The enantiomeric sense of asymmetric reduction using the (R)- or (S)-oxazaborolidines and a complementary asymmetric reduction using LiAlH4 and N-methylephedrine was exactly that predicted. The C-1 absolute configuration of (S,S)-carbamate 22b was in fact fully confirmed by a single-crystal X-ray crystallographic study. Hence, the four empirically derived methods for establishing absolute configuration of the various enynols were mutually consistent. The analogues 5a and 5b were submitted for biological evaluation of their relative ability, in relation to the reference 1-alpha,25-dihydroxyvitamin D3 (3, 1-alpha,25-(OH)2-D3), to stimulate intestinal calcium absorption (ICA) and bone calcium mobilization (BCM) under in vivo conditions. Analogue 5a was 20% and <10% while analogue 5b was <20% and <10% as active as a 100 pmol dose of 1-alpha,25-(OH)2-D3 for ICA and BCM, respectively. In addition, 5a and 5b were 14.5 +/- 5.7% and 1.23 +/- 0.38%, respectively, as effective as 1-alpha,25-(OH)2-D3 in binding, under in vitro conditions, to a chick intestinal nuclear receptor.
    DOI:
    10.1021/jo00040a025
点击查看最新优质反应信息

同类化合物

(5β,6α,8α,10α,13α)-6-羟基-15-氧代黄-9(11),16-二烯-18-油酸 (3S,3aR,8aR)-3,8a-二羟基-5-异丙基-3,8-二甲基-2,3,3a,4,5,8a-六氢-1H-天青-6-酮 (2Z)-2-(羟甲基)丁-2-烯酸乙酯 (2S,4aR,6aR,7R,9S,10aS,10bR)-甲基9-(苯甲酰氧基)-2-(呋喃-3-基)-十二烷基-6a,10b-二甲基-4,10-dioxo-1H-苯并[f]异亚甲基-7-羧酸盐 (1aR,4E,7aS,8R,10aS,10bS)-8-[((二甲基氨基)甲基]-2,3,6,7,7a,8,10a,10b-八氢-1a,5-二甲基-氧杂壬酸[9,10]环癸[1,2-b]呋喃-9(1aH)-酮 (+)顺式,反式-脱落酸-d6 龙舌兰皂苷乙酯 龙脑香醇酮 龙脑烯醛 龙脑7-O-[Β-D-呋喃芹菜糖基-(1→6)]-Β-D-吡喃葡萄糖苷 龙牙楤木皂甙VII 龙吉甙元 齿孔醇 齐墩果醛 齐墩果酸苄酯 齐墩果酸甲酯 齐墩果酸溴乙酯 齐墩果酸二甲胺基乙酯 齐墩果酸乙酯 齐墩果酸3-O-alpha-L-吡喃鼠李糖基(1-3)-beta-D-吡喃木糖基(1-3)-alpha-L-吡喃鼠李糖基(1-2)-alpha-L-阿拉伯糖吡喃糖苷 齐墩果酸 beta-D-葡萄糖酯 齐墩果酸 beta-D-吡喃葡萄糖基酯 齐墩果酸 3-乙酸酯 齐墩果酸 3-O-beta-D-葡吡喃糖基 (1→2)-alpha-L-吡喃阿拉伯糖苷 齐墩果酸 齐墩果-12-烯-3b,6b-二醇 齐墩果-12-烯-3,24-二醇 齐墩果-12-烯-3,21,23-三醇,(3b,4b,21a)-(9CI) 齐墩果-12-烯-3,21,23-三醇,(3b,4b,21a)-(9CI) 齐墩果-12-烯-3,11-二酮 齐墩果-12-烯-2α,3β,28-三醇 齐墩果-12-烯-29-酸,3,22-二羟基-11-羰基-,g-内酯,(3b,20b,22b)- 齐墩果-12-烯-28-酸,3-[(6-脱氧-4-O-b-D-吡喃木糖基-a-L-吡喃鼠李糖基)氧代]-,(3b)-(9CI) 齐墩果-12-烯-28-酸,3,7-二羰基-(9CI) 齐墩果-12-烯-28-酸,3,21,29-三羟基-,g-内酯,(3b,20b,21b)-(9CI) 鼠特灵 鼠尾草酸醌 鼠尾草酸 鼠尾草酚酮 鼠尾草苦内脂 黑蚁素 黑蔓醇酯B 黑蔓醇酯A 黑蔓酮酯D 黑海常春藤皂苷A1 黑檀醇 黑果茜草萜 B 黑五味子酸 黏黴酮 黏帚霉酸